Personal information

No personal information available

Activities

Collapse all

Works (4)

Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain

Pancreatology
2024-11 | Journal article
DOI: 10.1016/j.pan.2024.09.016
Contributors: Jami L Saloman; Kristofer Jennings; Kimberly Stello; Shuang Li; Anna Evans Phillips; Kristen Hall; Evan L. Fogel; Santhi Swaroop Vege; Dana K. Andersen; William E. Fisher et al.
Source: check_circle
Crossref

Circulating immune signatures in chronic pancreatitis with and without preceding acute pancreatitis: A pilot study

Pancreatology
2024-05 | Journal article
DOI: 10.1016/j.pan.2024.02.012
Contributors: Rasmus Hagn-Meincke; Dhiraj Yadav; Dana K. Andersen; Santhi Swaroop Vege; Evan L. Fogel; Jose Serrano; Melena D. Bellin; Mark D. Topazian; Darwin L. Conwell; Liang Li et al.
Source: check_circle
Crossref

Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

JMIR Research Protocols
2024-03-07 | Journal article
DOI: 10.2196/50513
Contributors: Evan L Fogel; Jeffrey J Easler; Ying Yuan; Dhiraj Yadav; Darwin L Conwell; Santhi Swaroop Vege; Samuel Y Han; Walter Park; Vanessa Patrick; Fletcher A White
Source: check_circle
Crossref

Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects (Preprint)

2023-07-03 | Preprint
DOI: 10.2196/preprints.50513
Contributors: Evan L Fogel; Jeffrey J Easler; Ying Yuan; Dhiraj Yadav; Darwin L Conwell; Santhi Swaroop Vege; Samuel Y Han; Walter Park; Vanessa Patrick; Fletcher A White
Source: check_circle
Crossref
How many people are using ORCID?